NCT06989216 Multi-modal Quantitative Imaging of the Skin
| NCT ID | NCT06989216 |
| Status | Recruiting |
| Phase | — |
| Sponsor | HJN Sverige AB/Neko Health |
| Condition | Skin Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 8,000 participants |
| Start Date | 2023-02-01 |
| Primary Completion | 2026-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 8,000 participants in total. It began in 2023-02-01 with a primary completion date of 2026-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial is about evaluating the suitability of multi-modal imaging technology, which covers virtually the entire body, to evaluate the possibility of screening and early detection of disease.
Eligibility Criteria
Inclusion criteria: * Adult patients that are part of the regular healthcare patient flow at the investigational sites, or as separately invited to participate in this investigation. * Patients with signed informed consent Exclusion criteria: * Cognitive impairment * Patients unable to understand the oral and written study information in Swedish or English * Other severe disorder or terminal disease * Patients unable to provide an informed consent * Patients not able to keep balance, while standing up with closed eyes, without any aid * Claustrophobic patients
Contact & Investigator
Andreea Valdman, MD
PRINCIPAL INVESTIGATOR
Neko Health AB
Frequently Asked Questions
Who can join the NCT06989216 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Skin Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06989216 currently recruiting?
Yes, NCT06989216 is actively recruiting participants. Contact the research team at mattias@nekohealth.com for enrollment information.
Where is the NCT06989216 trial being conducted?
This trial is being conducted at Stockholm, Sweden, Stockholm, Sweden, Stockholm, Sweden.
Who is sponsoring the NCT06989216 clinical trial?
NCT06989216 is sponsored by HJN Sverige AB/Neko Health. The principal investigator is Andreea Valdman, MD at Neko Health AB. The trial plans to enroll 8,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.